Medico Remedies Limited (NSE:MEDICO)

Market Cap	4.66B
Revenue (ttm)	1.51B
Net Income (ttm)	88.52M
Shares Out	n/a
EPS (ttm)	1.06
PE Ratio	52.60
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	931,706
Average Volume	1,902,475
Open	58.78
Previous Close	58.13
Day's Range	55.55 - 58.78
52-Week Range	34.80 - 80.00
Beta	0.23
RSI	42.96
Earnings Date	May 9, 2025

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 193
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDICO

Financial Performance

In 2023, Medico Remedies's revenue was 1.45 billion, an increase of 3.19% compared to the previous year's 1.40 billion. Earnings were 82.91 million, an increase of 14.49%.